Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium (P.N., P.M., M.D., W.M.).
Doctoral School for Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium (P.N., P.H., P.M.).
Circ Heart Fail. 2018 Jul;11(7):e004763. doi: 10.1161/CIRCHEARTFAILURE.117.004763.
Large networks of interstitial glycosaminoglycans help to regulate water and electrolyte homeostasis. The relation between dermal interstitial alterations and occurrence of edema in heart failure patients with reduced ejection fraction (HFrEF) is unknown. We hypothesize that in HFrEF patients (1) interstitial glycosaminoglycan density is increased, (2) changes in the interstitial glycosaminoglycan network are associated with interstitial fluid accumulation, and (3) there is a link between the interstitial glycosaminoglycan network and the renin-angiotensin-aldosterone system.
Two punch biopsies of the skin were obtained in healthy subjects (n=18) and HFrEF patients (n=29). Alcian blue staining and immunostaining for the angiotensin II type 1 receptor was performed. After obtaining tissue water content, total interstitial glycosaminoglycan (uronic acid) and sulfated glycosaminoglycan were quantified. A venous blood sample, clinical examination, and echocardiography were obtained. A significantly higher interstitial glycosaminoglycan content was observed in HFrEF patients compared with healthy subjects (uronic acid: 13.0±4.2 versus 9.6±1.6 μg/mg; =0.002; sulfated glycosaminoglycan: 14.1 [11.7; 18.1] versus 10.0 [9.1; 10.8] μg/mg; <0.001). Uronic acid and sulfated glycosaminoglycan density were strongly associated with tissue water content and peripheral edema (uronic acid: ρ=0.66; <0.0001 and sulfated glycosaminoglycan: τ=0.58; <0.0001). Expression of the angiotensin II type 1 receptor was found on dermal cells, although use of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker was associated with significantly lower levels of interstitial glycosaminoglycans in HFrEF patients.
Interstitial glycosaminoglycan concentration is significantly increased in HFrEF patients compared with healthy subjects and correlated with tissue water content and clinical signs of volume overload. A better appreciation of the interstitial compartment might improve management of volume overload in HF.
大量的细胞间质糖胺聚糖有助于调节水和电解质的动态平衡。心力衰竭射血分数降低(HFrEF)患者皮肤细胞间质改变与水肿发生之间的关系尚不清楚。我们假设在 HFrEF 患者中:(1)细胞间质糖胺聚糖密度增加;(2)细胞间质糖胺聚糖网络的变化与细胞间质液蓄积相关;(3)细胞间质糖胺聚糖网络与肾素-血管紧张素-醛固酮系统之间存在联系。
健康受试者(n=18)和 HFrEF 患者(n=29)各取两块皮肤活检样本。进行阿尔辛蓝染色和血管紧张素 II 型 1 受体免疫染色。获取组织水含量后,定量分析总细胞间质糖胺聚糖(糖醛酸)和硫酸化糖胺聚糖。采集静脉血样本、进行临床检查和超声心动图检查。与健康受试者相比,HFrEF 患者的细胞间质糖胺聚糖含量显著升高(糖醛酸:13.0±4.2 比 9.6±1.6 μg/mg;=0.002;硫酸化糖胺聚糖:14.1[11.7;18.1]比 10.0[9.1;10.8] μg/mg;<0.001)。糖醛酸和硫酸化糖胺聚糖密度与组织水含量和外周水肿高度相关(糖醛酸:ρ=0.66;<0.0001和硫酸化糖胺聚糖:τ=0.58;<0.0001)。尽管血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂的使用与 HFrEF 患者的细胞间质糖胺聚糖水平显著降低相关,但在真皮细胞上发现了血管紧张素 II 型 1 受体的表达。
与健康受试者相比,HFrEF 患者的细胞间质糖胺聚糖浓度显著升高,并与组织水含量和容量超负荷的临床体征相关。更好地了解细胞间质可能会改善心力衰竭患者容量超负荷的管理。